Teniposide

替尼泊苷

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTeniposide
Drug Alias Name鬼臼噻吩苷teniposidum替尼泊甘替尼泊甙卫萌 +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTopoisomerase II inhibitors
TargetsTopoisomerase II
Therapy Area/IndicationsNeoplasm MetastasisUrinary Bladder NeoplasmsNeuroblastoma +[7] 
Global Approved IndicationsNeoplasm MetastasisUrinary Bladder NeoplasmsNeuroblastoma +[7] 
Approved Indications in ChinaNeoplasm MetastasisUrinary Bladder NeoplasmsNeuroblastoma +[7] 
Original Approved Country/TerritoryUnited States
Original Approved Date1992/07/14
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHq Speciality Pharma
China Registration ClassN/A

Develop Information

Active CompaniesChina Resources Double-Crane Pharmaceutical Co Ltd
Inactive CompaniesHq Speciality Pharma
Active IndicationsNeoplasm MetastasisUrinary Bladder NeoplasmsNeuroblastoma +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeL01CB02
Related LinksWikipediaDrugBankKEGG